Clinical response and relapse in a patient (UPN1) receiving PKC412. Serial white blood cell counts (A) and percentages of bone marrow blast infiltration (B) at several time points are depicted. On day 280, the patient had a fulminant relapse while on PKC412 treatment. Bone marrow aspiration was performed on days 1, 28, 84, 204, and 280.